Steven Cohen’s ALX Oncology ALXO Stock Holding History

Steven Cohen’s Portfolio ALXO Stock Details ALXO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	–	Sell	-41,095	Closed	-$82.4K	–	3959
2026 Q1	$82.4K	Buy	41,095 +20,878	+103%	+$39.8K	﹤0.01%	3630
2025 Q4	$22.8K	Buy	+20,217	New	+$30.6K	﹤0.01%	3829
2024 Q3	–	Sell	-304,100	Closed	-$1.83M	–	1954
2024 Q2	$1.83M	Buy	+304,100	New	+$3.74M	﹤0.01%	1119
2024 Q1	–	Sell	-913,700	Closed	-$13.6M	–	2142
2023 Q4	$13.6M	Buy	+913,700	New	+$8.67M	0.03%	579
2023 Q2	–	Sell	-13,556	Closed	-$61.3K	–	2135
2023 Q1	$61.3K	Sell	13,556 -71,444	-84%	-$541K	﹤0.01%	1747
2022 Q4	$958K	Sell	85,000 -297,500	-78%	-$3.34M	﹤0.01%	1055
2022 Q3	$3.66M	Buy	+382,500	New	+$4.46M	0.01%	809

Other funds holding ALXO

RCM

RA Capital Management Boston, Massachusetts $11.5B AUM 168.77% 1-Year Est. Return

venBio Partners San Francisco, California $519M AUM 339.42% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Redmile Group San Francisco, California $1.49B AUM 208.7% 1-Year Est. Return

Blackstone Inc New York $32.9B AUM 23.66% 1-Year Est. Return

DCM

Driehaus Capital Management Chicago, Illinois $17.3B AUM 211.34% 1-Year Est. Return

SCM

Silverarc Capital Management Boston, Massachusetts $962M AUM 524.64% 1-Year Est. Return

TCM

TCG Crossover Management Palo Alto, California $4.16B AUM 983.43% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Vivo Capital Palo Alto, California $1.1B AUM 799.93% 1-Year Est. Return

Steven Cohen's ALXO Position: Q2 2026 in Review

Steven Cohen sold out of ALX Oncology (ALXO) in Q2 2026, closing a stake of 41,095 shares — an estimated $82.4K sold.

Steven Cohen first reported a position in ALXO in Q3 2022 and held it in 7 quarters. The position peaked at $13.6M in Q4 2023. 93 funds tracked by Wall St. Rank hold ALXO as of Q2 2026.

Steven Cohen reported no remaining ALX Oncology position as of Q2 2026 after selling out during the quarter.
Steven Cohen sold 41,095 ALX Oncology shares in Q2 2026, an estimated $82.4K.
Steven Cohen first reported a position in ALX Oncology in Q3 2022 and held it in 7 quarters.
Steven Cohen's ALX Oncology position peaked at $13.6M in Q4 2023.
93 funds tracked by Wall St. Rank held ALX Oncology as of Q2 2026.

Based on Point72 Asset Management's 13F filing for Q2 2026, filed 14 Aug 2026.